Melanoma Matters Pod
Melanoma Matters
From the UK to the USA - Melanoma Matters is on a mission! Hosts James Larkin and Sapna Patel are spreading the word on melanoma, one podcast at a time. Tune in for a critical review of the literature and a discussion of how we incorporate the data into our practices...across the pond(s). #MelanomaMatters video podcast
Be sure to visit the podcast's website and support the creator: www.melanomamatters.com
Author
Melanoma Matters Pod
Category
Podcast website
Latest episode
Oct 16, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Ep 70: Best of ASCO colon.... 2025 ;) 25.06.2025 48:38
You wanted it, we gave it... best of ASCO ...colon...2025 :D In this episode, hosts James and Sapna discuss the key highlights from ASCO 2025, focusing on significant abstracts related to melanoma treatment. They delve into the implications of adrenal insufficiency, the 5 year, final results of Lifileucel, and the ongoing debate between neoadjuvant and adjuvant therapies. The conversation also exp...
Ep 69: Guest Monty Pal 24.06.2025 36:45
Summary In this episode, Sapna Patel and James Larkin engage with Monty Pal from City of Hope, discussing his unique journey into oncology, the significance of the microbiome in cancer treatment, and the impact of diet and lifestyle on patient outcomes. They explore current research, including clinical trials involving fecal microbiome transplants and the potential of specific bacteria to enhance...
Ep 68: GDF-15 antibody GODFATHER trial 24.06.2025 28:46
Summary In this episode of Melanoma Matters, hosts Sapna Patel and James Larkin discuss the Godfather 15 trial, focusing on the neutralizing GDF 15 antibody and its implications in overcoming PD-1 and anti-PD-L1 resistance in solid tumors. They explore the background of GDF-15, its role in immune suppression, and the trial's methodology, including safety and efficacy results. The conversation...
Ep 67: SITC white paper on ICI resistance 07.04.2025 33:45
Summary In this conversation, James Larkin and Sapna Patel discuss the consensus definitions for resistance to immune checkpoint inhibitors, focusing on a recent paper from the Journal of Immunotherapy of Cancer. They explore the complexities of primary and secondary resistance, the importance of defining these terms for clinical trials, and the challenges in trial design and control arms. The dis...
Ep 66: Ponsegromab for cancer cachexia 30.03.2025 43:13
Summary In this episode of Melanoma Matters, James Larkin and Sapna Patel discuss the recent advancements in understanding and treating cancer cachexia, particularly focusing on the drug ponsegramab. They explore the implications of cachexia across different cancer types, the role of cytokine GDF-15, and the importance of nutrition and physical activity in managing cachexia. They opine on body wei...
Ep 65: Opdivo Qvantig (subcutaneous formulation) 28.03.2025 47:54
Summary In this conversation, Sapna Patel and James Larkin discuss the recent approval of Opdivo Qvantiq, a subcutaneous formulation of nivolumab, and its implications for oncology treatment. They explore the Checkmate 6-7-T study that led to its approval, the efficacy and safety of the new formulation, and the broader regulatory landscape. The discussion also touches on patient perspectives regar...
Ep 64: Guest Clare Turnbull Part 2 24.03.2025 46:11
In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel pick up with Part 2 of 2 - a deep conversation with Claire Turnbull - about the complexities of cancer screening, overdiagnosis, and the role of genetic testing. They explore the implications of screening practices illustrated by the Gilbert Welch paradigm, the challenges faced in patient management, and the future of genetic...
Ep 63: Guest Clare Turnbull Part 1 20.03.2025 28:45
Summary In this episode of Melanoma Matters, hosts Sapna Patel and James Larkin welcome Clare Turnbull, a clinical geneticist in London, to discuss her journey from studying mathematics to medicine, her work in cancer genetics, and the impact of COVID-19 on healthcare. The conversation explores the role of genetic testing in melanoma, the challenges of public health in cancer treatment, and the on...
Ep 62: Post PD-1 studies 18.03.2025 19:26
Summary On mountain emergencies...Sapna's had them, James denies them...This conversation delves into the treatment options available for patients with advanced melanoma who have progressed after anti PD-1 therapy. The discussion covers various clinical studies, response rates, and the implications of combination therapy post-PD1 progression. James and Sapna conclude that while combination the...
Ep 61: Guest Inge Marie Svane 12.03.2025 24:28
Summary In this episode of Melanoma Matters, host Sapna Patel and James Larkin welcome guest Inge Marie Svane to discuss the evolution and future of cancer immunotherapy, particularly focusing on cellular therapy for melanoma. Inge Marie shares her extensive background in the field, the establishment of a cancer immune therapy center in Denmark, and the historical context of cellular therapy. The...
Ep 60: Melanoma & Kidney Cancer w/ Mike Atkins 02.03.2025 39:08
Welcome to Season 2! In this episode of Melanoma Matters, hosts Sapna Patel and James Larkin engage with Michael Atkins from Georgetown University to discuss the advancements in melanoma and kidney cancer treatments, particularly focusing on immunotherapy and cytokine treatments. They explore the groundbreaking DreamSeq trial that compares immunotherapy and targeted therapy in 1L melanoma. Keyword...
Ep 59: 2024 Reflections 13.02.2025 43:15
Time to exhale... and reflect upon 2024. In this episode, hosts Sapna Patel and James Larkin reflect on their professional and personal experiences from 2024, discussing highlights, lowlights, and the impact of loss in the medical community. They share their intentions and goals for 2025, emphasizing personal bests, leadership , and the importance of friendships. The conversation also touches on c...
Ep 58: Best of 2024: SMR 27.12.2024 23:59
Summary Favorite holiday songs... perhaps unexpectedly one of our hosts faves is Christmas Card From a Hooker in Minneapolis ... guess which? In another Best of 2024 episode of Melanoma Matters, hosts Sapna Patel and James Larkin discuss key findings from the Society for Melanoma Research (SMR) meeting. They spotlight the TIL for CNS mets study, KEYMAKER U02 Substudy 02D, IMA203, KeyVibe, and the...
Ep 57: Best of 2024: ESMO 23.12.2024 28:37
Summary Voicing punctuation #2 ... In this episode of Melanoma Matters, hosts Sapna Patel and James Larkin discuss their second episode in the "Best of 2024" series and review the highlights from the 2024 ESMO Congress. They discuss the final analysis of CheckMate 067, long-term data from KEYNOTE 006, DMFS from NADINA, and the KEYMAKER U02 Substudy 02C. The conversation also covers resul...
Ep 56: Best of 2024: ASCO 23.12.2024 33:18
Summary Verbalizing punctuation for laughs...background wood noises ... and out of office replies get things started. In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel record their first in a series of "Best of 2024" and review highlights from the ASCO Annual Meeting. They focus on 4 significant trials: NADINA, COMBI-AD, KEYNOTE 942, and RELATIVITY 048. James &...
Ep 55: VIBE Intro - Give Us Your Feedback 12.12.2024 3:05
In this episode we are calling VIBE - Voicing Interesting Bits from Everyone - we want to hear from YOU! We've opened an email address to field your questions, concerns, feedback and input. <melanomamatterspod@gmail.com> While we cannot answer specific patient case questions, this is a great forum to clarify any questions around the data. Our plan is to record an episode discussing the q...
Ep 54: All things MSLT with Mark Faries 10.12.2024 38:27
Summary In this episode of Melanoma Matters, hosts Sapna Patel and James Larkin welcome surgical oncologist Mark Faries to discuss the evolution of surgical practices in melanoma, particularly focusing on sentinel lymph node biopsy and the implications of recent clinical trials. They explore the historical context of lymph node surgeries, the significance of nomograms in predicting patient outcome...
Ep 53: Guest Toni Ribas 10.12.2024 26:35
Summary In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel welcome their first live guest, Toni Ribas. The conversation covers the evolution of melanoma treatments, the challenge of treatment resistance, and the importance of clinical trials. The episode emphasizes the need for continuous innovation and the importance of understanding the complexities of the immune system in c...
Ep 52: COLUMBUS 7-year follow-up 10.11.2024 37:14
Summary In this episode of Melanoma Matters, James tells us about his path to oncology (thank you, Emma) via John Newsom-Davis, the Jeremy Bentham pub, and Hammersmith Hospital. Later, hosts Sapna Patel and James Larkin discuss the COLUMBUS 7-year data of targeted therapy for metastatic melanoma - treatment efficacy, toxicity, and long-term patient management. They explore the nuances of treatment...
Ep 51: Exercise Oncology and TIL for CNS mets with Allison Betof Warner 14.10.2024 28:35
Teaser : Find out Allison's favorite body part, had she been an orthopedic surgeon (and James' 2nd favorite.. from the movie Sleeper) Summary In this episode of Melanoma Matters, hosts Sapna Patel and James Larkin welcome Dr. Allison Betof-Warner, Director of the Advanced Melanoma Program at Stanford University. The conversation explores Dr. Betof-Warner's journey into oncology, her passion for Cr...
Ep 50: ADAPT-IT Study 14.10.2024 31:57
Summary Gulf oysters and FATE get a shoutout in this episode of Melanoma Matters. Hosts James Larkin and Sapna Patel discuss the ADAPT-IT study, focusing on adaptive dosing strategies in immunotherapy for melanoma. They explore the study's design, results, and implications for clinical practice, including the potential for reduced dosing based on early response assessments. Keywords ADAPT-IT study...
Ep 49: Melanoma Patient Network Europe with Bettina Ryll 14.10.2024 39:41
Summary In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel engage with Bettina Ryll, founder of the Melanoma Patient Network Europe (MPNE). Bettina shares her personal journey from being a physician to becoming a patient advocate after her husband's battle with metastatic melanoma. The conversation explores the evolution of patient support networks, the challenges faced in hea...
Ep 48: CM 067 Final, 10-year analysis with Jedd Wolchok 14.10.2024 34:47
Summary In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel engage with Jedd Wolchok, a prominent figure in oncology, to discuss his journey into the field, the evolution of immunotherapy, particularly the Checkmate-067 trial, and the long-term outcomes for melanoma patients. The conversation highlights the importance of collaboration in clinical trials, the significance of und...
Ep 47: TRICOTEL with Andreas Schmitt 14.10.2024 40:47
Summary In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel welcome Dr. Andreas Schmitt to discuss various aspects of melanoma treatment, including the importance of supplementary data in clinical trial reports, the implications of the TRICOTEL study, and the role of PD-L1 as a biomarker. The conversation highlights the significance of peer review and academic collaboration in...
Ep 46: Cemiplimab + Fianlimab (first report) 14.10.2024 24:00
Summary *Warning* with apologies! There is a change in sound at 11:11 mark that might necessitate a lower volume output. Hosts James Larkin has a beef with the first word of the cemiplimab + fianlimab JCO publication. He's living vicariously through Sapna's snowboarding plans for the season (if the record high temps ever stop). They continue to struggle with Farenheit to Centrigrade conversion. In...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.